Altered expression of MZB1 in tumor cells is associated with DNA damage response and cell cycle regulation, highlighting its multifaceted roles in ovarian cancer and suggesting its potential as a therapeutic target [36]. This evidence concerns the gene MZB1 and ovarian carcinoma.